ABL is pleased to announce the development and future release of the first version of MicrobioChek, a generic downstream analysis software intended to be used by microbiology laboratories for micro-organism related molecular analysis.
Developed with the support of a RDI grant from the Ministry of the Economy in Luxembourg, this innovative tool will leverage ABL efforts toward the development and commercialization of generic end-to-end platforms used for optimizing the management of infectious diseases in the new era of Personalized Disease, Precision Medicine and optimal use of Molecular biomarkers.